• January 18, 2021

Adrenoleukodystrophy Pipeline Review, H2 2020 Edition - Therapeutics Development and Assessment, Drug Profiles, Dormant Projects, Product Development Milestones, Competitive Landscape - ResearchAndMarkets.com - Odessa American: Business

e-Edition Subscribe

Adrenoleukodystrophy Pipeline Review, H2 2020 Edition - Therapeutics Development and Assessment, Drug Profiles, Dormant Projects, Product Development Milestones, Competitive Landscape - ResearchAndMarkets.com

Font Size:
Default font size
Larger font size

Posted: Tuesday, January 12, 2021 10:10 am | Updated: 10:40 am, Tue Jan 12, 2021.

DUBLIN--(BUSINESS WIRE)--Jan 12, 2021--

The "Adrenoleukodystrophy - Pipeline Review, H2 2020" drug pipelines has been added to ResearchAndMarkets.com's offering.

Adrenoleukodystrophy - Pipeline Review, H2 2020, provides comprehensive information on the therapeutics under development for Adrenoleukodystrophy (Genetic Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Adrenoleukodystrophy (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Adrenoleukodystrophy (Adrenomyeloneuropathy/ Schilder-Addison Complex) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical and Discovery stages are 1, 2, 2, 1, 4 and 3 respectively. Similarly, the Universities portfolio in Phase II, Phase I and Preclinical stages comprises 2, 1 and 2 molecules, respectively.

Adrenoleukodystrophy (Genetic Disorders) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.


  • The pipeline guide provides a snapshot of the global therapeutic landscape of Adrenoleukodystrophy (Genetic Disorders).
  • The pipeline guide reviews pipeline therapeutics for Adrenoleukodystrophy (Genetic Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Adrenoleukodystrophy (Genetic Disorders) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Adrenoleukodystrophy (Genetic Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Adrenoleukodystrophy (Genetic Disorders)

Reasons to Buy

  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Adrenoleukodystrophy (Genetic Disorders).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Adrenoleukodystrophy (Genetic Disorders) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Key Topics Covered:


Adrenoleukodystrophy - Overview

Adrenoleukodystrophy - Therapeutics Development

Adrenoleukodystrophy - Therapeutics Assessment

Adrenoleukodystrophy - Companies Involved in Therapeutics Development

Adrenoleukodystrophy - Drug Profiles

Adrenoleukodystrophy - Dormant Projects

Adrenoleukodystrophy - Discontinued Products

Adrenoleukodystrophy - Product Development Milestones


Companies Mentioned

  • Applied Genetic Technologies Corp
  • Ashvattha Therapeutics LLC
  • bluebird bio Inc
  • Magenta Therapeutics Inc
  • MedDay SA
  • Minoryx Therapeutics sl
  • NeuroVia Inc
  • Orpheris Inc
  • Poxel SA
  • Recursion Pharmaceuticals Inc
  • SwanBio Therapeutics Ltd
  • Viking Therapeutics Inc

For more information about this drug pipelines report visit https://www.researchandmarkets.com/r/p8jg55

View source version on businesswire.com:https://www.businesswire.com/news/home/20210112005801/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900



SOURCE: Research and Markets

Copyright Business Wire 2021.

PUB: 01/12/2021 11:10 AM/DISC: 01/12/2021 11:10 AM


© 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Odessa, TX

Current Conditions

Humidity: 56%
Winds: S at 8mph
Feels Like: 34°

Your Extended Forecast


High 59°/Low 36°
Mainly clear. Lows overnight in the mid 30s.


High 69°/Low 36°
Abundant sunshine. Highs in the upper 60s and lows in the mid 30s.


High 44°/Low 36°
Mostly cloudy. Highs in the mid 40s and lows in the mid 30s.


High 50°/Low 41°
Mostly cloudy. Highs in the low 50s and lows in the low 40s.
Online Features

Pet Central


Having a pet is a lot of responsibility, and we’ll help by giving you lots of tips and tricks! More >>



Our fitness articles will help teach you how to work out with gym- and home-based exercises. More >>



Enjoy the crosswords challenge in our free daily puzzles, from the harder Sunday crossword to the quicker daily. More >>



Every Sudoku has a unique solution that can be reached logically. Enter numbers into the blank spaces so that each row, column and 3x3 box contains the numbers 1 to 9. More >>

  • ALL-ACCESS: Subscribe to our e-edition and premium website at myoaoa.com.
    You can read your daily newspaper without taking a walk to the driveway.
    Look back at yesterday's newspaper, or issues from months ago with our archive feature.
    Call circulation at 432-337-7314 to sign up today.